Independent Data Monitoring Committee (idmc) - Cancer Science

Relevant Publications

A Landscape of Methodology and Implementation of Adaptive Designs in Cancer Clinical Trials.

Issue Release: 2024

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study.

Issue Release: 2021

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.

Issue Release: 2020

Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.

Issue Release: 2017

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.

Issue Release: 2017

[Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial].

Issue Release: 2016

Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.

Issue Release: 2015

On independent data monitoring committees in oncology clinical trials.

Issue Release: 2014

[Enzalutamide-a novel androgen receptor inhibitor that provides treatment options for patients with castration-resistant prostate cancer].

Issue Release: 2014

Afatinib in the treatment of breast cancer.

Issue Release: 2014

When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill children.

Issue Release: 2013

A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer.

Issue Release: 2009

Early stopping of clinical trials.

Issue Release: 2005

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

Issue Release: 2005

SPOT GRADE II: Clinical Validation of a New Method for Reproducibly Quantifying Surgical Wound Bleeding: Prospective, Multicenter, Multispecialty, Single-Arm Study.

Issue Release: 0000

What is the Role of Glucose in Cancer?

How Do Tyrosine Kinase Inhibitors Work?

How is Sinusitis Diagnosed?

What Lifestyle Changes are Necessary?

What is the Role of Nutrition in Mental Health?

What is Laryngoscopy?

How Is NER Linked to Cancer Therapy?

Why Do Adverse Reactions Occur?

How Can Families Maintain Normalcy and Routine?

What is Aspartate Transcarbamoylase?

Partnered Content Networks

Relevant Topics